Reading Time: 5 minutesClinical trial sponsors are navigating a shifting landscape; NIH funding cuts are fueling site staff shortages, and FDA resource reductions are risking slower regulatory reviews. At the same time, evolving reimbursement frameworks within healthcare are impacting budgets and heightening cost concerns. The result? Less capital flowing into drug development programs, decreased research capacity at sites, […]
Article




